hotspot -WSS

hotspot

author：fashion 2025-09-29 01:45:34 - browse：33

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Brain technologies pose threats that are all too real, experts warn

leisure time

WSS

The future of health care in the House

Phenylephrine and the overlooked value of the placebo effect

Black vets could get higher VA benefits if race not used in lung test

AltruBio raises $225 million to develop ulcerative colitis drug

How a small hospital in rural Puerto Rico survived Hurricane Maria

The future of health care in the House

leisure time

hotspot

Sign up for Morning Rounds

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Brain technologies pose threats that are all too real, experts warn

Affirmative action in medical school literally saved lives

Is it ever OK for doctors to lie to their patients?

How one medical school became remarkably diverse

VC firm General Catalyst wants to buy a health system

Alkermes shareholders re

FDA authorizes Novavax’s updated Covid

Jerome Adams on the need for new antivirals for Covid

Has Bernie Sanders reached the limit of his pharma bullying effort?

knowledge

Crowdfunding for medical bills sidesteps core problem, author says

Brain MRIs reveal impact of 'toxic stress' on Black children

HHS's proposed rule does nothing to address the climate crisis

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

GSK’s asthma push continues as drug succeeds in Phase 3 trials

PBM executives asked to testify by House panel

focus

leisure time

hotspot

leisure time